Researchers have recently developed a microfluidic technology that will help them to study the molecular basis of several severe diseases such as brain cancer, schizophrenia, addiction, etc. that have remained undetectable due to lack of advanced technologies. Unlike the standard method, the newly discovered method will allow the characterization of the epigenome using as few as 100 cells. Moreover, this technology will help to compare the normal and diseased epigenomes. This method will detect useful markers and patterns so that it can be used for accurate medicine based on the epigenomic features of an individual patient.
Disclaimer: The above article has been aggregated by a computer program and summarised by an Steamdaily specialist. You can read the original article at phys
